These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2145063)

  • 1. Dehydroepiandrosterone sulfate and breast cancer risk.
    Barrett-Connor E; Friedlander NJ; Khaw KT
    Cancer Res; 1990 Oct; 50(20):6571-4. PubMed ID: 2145063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer.
    Helzlsouer KJ; Gordon GB; Alberg AJ; Bush TL; Comstock GW
    Cancer Res; 1992 Jan; 52(1):1-4. PubMed ID: 1530765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer.
    Gordon GB; Bush TL; Helzlsouer KJ; Miller SR; Comstock GW
    Cancer Res; 1990 Jul; 50(13):3859-62. PubMed ID: 2141293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
    Alberg AJ; Gordon GB; Hoffman SC; Comstock GW; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
    Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood levels of dehydroepiandrosterone sulfate (DHEA-S) and the risk of breast cancer].
    Gomes P; Cassanas G; Halberg F; Hermida R; Robel P; Baulieu EE; Lakatua D; Haus E
    C R Acad Sci III; 1988; 306(7):261-4. PubMed ID: 2967730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
    Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
    Khaw KT
    J Endocrinol; 1996 Sep; 150 Suppl():S149-53. PubMed ID: 8943798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.
    Barrett-Connor E; Khaw KT; Yen SS
    N Engl J Med; 1986 Dec; 315(24):1519-24. PubMed ID: 2946952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sex hormones and breast cancer risk factors in postmenopausal women.
    Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin.
    Alberg AJ; Gordon GB; Genkinger JM; Hoffman SC; Selvin E; Comstock GW; Helzlsouer KJ
    Anticancer Res; 2001; 21(6A):4051-4. PubMed ID: 11911290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low plasma levels of dehydroepiandrosterone sulphate in HIV-positive patients coinfected with hepatitis C virus.
    Mauboussin JM; Mahamat A; Peyrière H; Rouanet I; Fabbro-Peray P; Daures JP; Vincent D
    HIV Med; 2004 May; 5(3):151-7. PubMed ID: 15139980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
    Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate.
    Comstock GW; Gordon GB; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 1993; 2(3):219-21. PubMed ID: 8318873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
    Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.